Prevalence and patterns of antidepressant drug use during pregnancy

European Journal of Clinical Pharmacology

Volumn 62, Issue 10, 2006, Pages 863-870

  Ververs, Tessa ^a   Kaasenbrood, Hans ^b   Visser, Gerard ^a   Schobben, Fred ^a   De Jong Van Den Berg, Lolkje ^c   Egberts, Toine ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VGZ Health Insurance Company   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antidepressants; Drug use; Pharmacoepidemiology; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DELIVERY; DEPRESSION; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; FREQUENCY ANALYSIS; GESTATION PERIOD; HEALTH CARE; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PREGNANCY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; DATABASES, FACTUAL; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; FLUOXETINE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; NETHERLANDS; PAROXETINE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTERS; PRESCRIPTIONS, DRUG; PREVALENCE; TIME FACTORS;

EID: 33749460866     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0177-0     Document Type: Article

References (28)

1. Hansen DG, Sondergaard J, Vach W, Gram LF, Rosholm JU, Kragst J (2003) Antidepressant drug use in general practice: interpractice variation and association with practice characteristics. Eur J Clin Pharmacol 59:143-149
2. De las Cuevas C, Sanz E (2004) Do therapeutic indications of antidepressants change from one year to another? Pharmacoepidemiol Dr S 13:309-314
3. Foundation for Pharmaceutical Statistics, Farmacie in cijfers. [Pharmacy in figures. Drug use of antidepressants is increasing] 2005 Pharmaceutisch Weekblad 140:767 or http://www.sfk.nl/publicaties/farmacie_in_cijfers/2005
4. Kallen B, Otterblad Olausson P (2006) Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21:221-222
5. Williams M, Wooltorton E (2005) Paroxetine(Paxil) and congenital malformations. Can Med Assoc J 173:1320-1321
6. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE (2003) Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142:402-408
7. Zeskind PS, Stephens LE (2004) Maternal Selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113:368-375
8. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354:579-587
9. Nonacs R, Cohen LS (2003) Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin N Am 26:547-562
10. Sanz EJ, De-las-Cuevas D, Kiuru A, Bate A, Edwards R (2005) Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365:482-487
11. Olesen C, Sorensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH (1999) Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group. Acta Obstet Gynecol Scand 78:686-692
12. Beyens MN, Guy C, Ratrema M, Ollagnier M (2003) Prescription of drugs to pregnant women in France: the HIMAGE study. Therapie 58:505-511
13. Schirm E, Meijer WM, Tobi H, de Jong-van den Berg LT (2004) Drug use by pregnant women and comparable non-pregnant women in the Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 114:182-188
14. Headley J, Northstone K, Simmons H, Golding J; ALSPAC Study Team (2004) Medication use during pregnancy: data from the Avon longitudinal study of parents and children. Eur J Clin Pharmacol 60:355-361
15. Egen-Lappe V, Hasford J (2004) Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur Clin Pharmacol 60:659-666
16. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191:398-407
17. Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Dr S 12:409-416
18. Schirm E, Tobi H, de Jong-van den Berg LTW (2004) Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 57:737-741
19. Mittendorf R, Williams MA, Berkey CS, Cotter PF (1990) The length of uncomplicated human gestation. Obstet Gynecol 75:929-932
20. Australian Drug Evaluation Committee. Medicines in Pregnancy Working Party, Prescribing Medicines in Pregnancy. Australian categorisation of drugs, 4th ed. [cited 3 September 2004]. Available from URL: http://www.health.gov.au/ tga/docs/html/medpreg.htm
21. Statistics Netherlands (CBS) Voorburg, the Netherlands. Available from URL: http://www.cbs.nl/enGB/default.htm
22. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G (2002) Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159:1889-1895
23. Nordeng H, Spigset O (2005) Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy. Drug Safety 28:565-581
24. Cohen LS, Altshuler LL, Stowe ZN, Faraone SV (2004) Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study. Psychother Psychosom 73:255-258
25. Jaiswal S, Coombs RC, Isbister GK (2003) Paroxetine withdrawal in a neonate with historical and aboratory confirmation. Eur J Pediatr 162:723-724
26. Gentile S (2005) SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome. CNS Drugs 19:623-633
27. Hines RN, Adams J, Buck GM, Faber W, Holson JF, Jacobson SW, Keszler M, McMartin K, Segraves RT, Singer LT, Sipes IG, Williams PL (2004) NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Fluoxetine. Birth Defects Res Part B71:193-280
28. Kallen B (2004) Fluoxetine use in early pregnancy. Birth Defects Res Part B 71:395-396